China Health Big Data

NCT03699228 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Jishuitan Hospital

Phase

Observational

Started

2017-12-01

Last updated

2025-08-17

Condition(s) studied

OsteoporosisObesityLiver Steatoses

Study summary

In this nationwide multi center study the investigators combine the low dose chest CT scan data with QCT technology, to measure the BMD of spine, VAT and liver fat in the health check subjects. The aim of this study is to evaluate the performance of QCT in the health check field, and further to evaluate the prevalence of osteoporosis, obesity and liver steatosis in health check population across China.

Eligibility

Sex

ALL

Min age

30 Years

Max age

90 Years

Healthy volunteers

Inclusion Criteria: health check subjects 30-90 years old low dose chest CT scan Exclusion Criteria: pregnant women metal implant in the CT scan area

Primary outcome measure(s)

The spinal volumetric bone mineral density (vBMD) — 2 year
The volumetric bone mineral density of L1-2 measured by QCT

Trial sites (6)

Facility	City	Region	Status
Wu Hu Yijishan Hospital	Wuhu	Anhui	Recruiting
Beijing Jishuitan hospital	Beijing	Beijing Municipality	Recruiting
The first affiliated hospital of Guiyang Medical University	Guiyang	Guizhou	Recruiting
The first affiliated hospital of Zhengzhou University	Zhengzhou	Henan	Recruiting
Hua Shan hospital	Shanghai	Shanghai Municipality	Recruiting
Shanghai Ruijin hospital	Shanghai	Shanghai Municipality	Recruiting

More Beijing Jishuitan Hospital trials in China

The Efficacy and Safety of Venostan in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures Recruiting

Chinese Second Hip Fracture Evaluation Recruiting

Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft Fractures Recruiting

Robot-Assisted Closed Reduction and Internal Fixation for Distal Femoral Fractures Recruiting

Does Medial Raw Anchor Necessary During Tendon Repair Combined With Microfracture Enrolling by invitation

Other trials for the same condition

A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects Starting soon

Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer Starting soon

The Effect of Semaglutide on Bone Health Starting soon

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS) Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03699228 on ClinicalTrials.gov ↗ ← All trials in China